A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB
about
A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB
description
scientific article published on 07 January 2020
@en
name
A pre-clinical validation plan ...... B/Rif Ultra and FluoroType MTB
@en
type
label
A pre-clinical validation plan ...... B/Rif Ultra and FluoroType MTB
@en
prefLabel
A pre-clinical validation plan ...... B/Rif Ultra and FluoroType MTB
@en
P2093
P50
P1433
P1476
A pre-clinical validation plan ...... B/Rif Ultra and FluoroType MTB
@en
P2093
Christoph Metzger-Boddien
Harald Hoffmann
Laura Olbrich
Marina Mihalic
Michael Lindner
Norbert Heinrich
Sabine Hofmann-Thiel
Sara Plesnik
Wolfgang Grasse
P304
P356
10.1371/JOURNAL.PONE.0227215
P577
2020-01-07T00:00:00Z